The EpiDirect® MGMT Methylation qPCR Assay represents a new and innovative approach allowing for direct quantification of MGMT promoter methylation by qPCR without prior DNA conversion.
The EpiDirect® technology is based on our unique INA® chemistry and includes an EpiPrimer™ oligonucleotide that specifically binds and primes amplification of methylated target DNA.
The assay is able to quantify MGMT promoter methylation using standard real-time PCR instruments* in just two hours with as little as 0.5 ng of unconverted input DNA.
Standard qPCR instrument procedure
No need for prior conversion of DNA
Results in less than 2 hours
1.5-3% LoD methylation
Minimal hands-on time
0.5-50 ng input DNA
CE IVD
Product Description PCR master mix and oligonucleotide mix for quantification of MGMT promoter methylation, positive and negative control
Format Ready-to-Use
Reactions 48
EpiDirect® MGMT Methylation qPCR Assay is a semi-automated real-time Polymerase Chain Reaction (PCR) assay intended for the direct, semi-quantitative analysis of the methylation status of the human DNA repair enzyme O6-methylguanine-DNA methyltransferase (MGMT) gene promoter.
The assay is intended for analysis of purified genomic DNA (gDNA) samples that without further pre-treatment can be used with real-time PCR systems for the detection and quantification of the methylation status of the MGMT promoter. Samples comprise Formalin-Fixed Paraffin-Embedded (FFPE) and fresh frozen biopsies and can be prepared using automated platforms or manual workflows.